SCHEMBL30359455

SCHEMBL30359455

CC(C)(S)[C@H](N)C(=O)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.52
ALDH1A1 P00352 4/20 0.52
PTGS1 P23219 1/20 0.52
TDP1 Q9NUW8 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
CES2 O00748 3/20 0.42
CES1 P23141 3/20 0.42
LMNA P02545 2/20 0.42
PGR P06401 1/20 0.41
ADRA2A P08913 1/20 0.41
ADRA2B P18089 1/20 0.41
HTR2A P28223 1/20 0.41
HRH1 P35367 1/20 0.41
KCNH2 Q12809 1/20 0.41
TSHR P16473 3/20 0.40
CYP3A4 P08684 2/20 0.40
HSD17B10 Q99714 2/20 0.40
MDM2 Q00987 1/20 0.40
POLB P06746 1/20 0.40
PARP1 P09874 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5058565 0.93 MAPT (0.46) MAPTALDH1A1PTGS1TDP1L3MBTL1
SCHEMBL8251886 0.84 TDP1 (0.47) MAPTALDH1A1TDP1L3MBTL1CES2
SCHEMBL3349906 0.82 TDP1 (0.45) MAPTALDH1A1PTGS1TDP1L3MBTL1
Phenylglyoxal SCHEMBL5493637 0.76 ALDH1A1 (0.56) MAPTALDH1A1PTGS1TDP1L3MBTL1
SCHEMBL3345719 0.74 CES1 (0.43) MAPTALDH1A1TDP1L3MBTL1CES2
SCHEMBL3345510 0.73 CES1 (0.45) MAPTALDH1A1TDP1L3MBTL1CES2
SCHEMBL3349186 0.73 TDP1 (0.44) MAPTALDH1A1TDP1L3MBTL1CES2
SCHEMBL4625011 0.73 MAPT (0.47) MAPTALDH1A1PTGS1TDP1LMNA
Phenylglycine SCHEMBL21814465 0.73 ALDH1A1 (0.62) MAPTALDH1A1PTGS1TDP1LMNA
Dealkylated Diethylpropion SCHEMBL25176894 0.73 TDP1 (0.52) MAPTALDH1A1TDP1L3MBTL1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4174057-B1 ARYLTETRAHYDROPYRIDAZINE DERIVATIVE OR SALT THEREOF, INSECTICIDE COMPRISING SAID COMPOUND, AND METHOD FOR USING SAID INSECTICIDE NIHON NOHYAKU CO LTD (JP) 2025-08-27 EP disclosed
US-20230303522-A1 ARYLTETRAHYDROPYRIDAZINE DERIVATIVE OR SALT THEREOF, INSECTICIDAL AGENT CONTAINING THE COMPOUND, AND METHOD OF USE THEREOF NIHON NOHYAKU CO., LTD. (JP) 2023-09-28 US disclosed
EP-4174057-A1 ARYLTETRAHYDROPYRIDAZINE DERIVATIVE OR SALT THEREOF, INSECTICIDE COMPRISING SAID COMPOUND, AND METHOD FOR USING SAID INSECTICIDE Nihon Nohyaku Co., Ltd. (JP) 2023-05-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303522-A1 ARYLTETRAHYDROPYRIDAZINE DERIVATIVE OR SALT THEREOF, INSECTICIDAL AGENT CONTAINING THE COMPOUND, AND METHOD OF USE THEREOF CYP4Z1, DDT, AADAC MAPT 3522/4885ALDH1A1 188/4885PTGS1 695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.